BioXcel Therapeutics
BTAI
#10047
Rank
HK$0.26 B
Marketcap
HK$10.80
Share price
-3.49%
Change (1 day)
-38.00%
Change (1 year)

BioXcel Therapeutics (BTAI) Fails to deliver data

Key failure to deliver metrics for BioXcel Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioXcel Therapeutics (BTAI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioXcel Therapeutics (BTAI) - since 2025

Volume in USD (price x number of shares), data since 2025

BioXcel Therapeutics (BTAI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$0.34 M-98.34%
2025HK$20.84 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ORIC Pharmaceuticals
ORIC
HK$7.81 MHK$17.82 M๐Ÿ‡บ๐Ÿ‡ธ USA